Statute of Limitations
Massachusetts: 3 years from discovery (M.G.L. c. 260, § 2A)
3 years from BIA-ALCL diagnosis or discovery of BIOCELL connection
Where to File in Massachusetts
Massachusetts has a 3-year personal injury statute under M.G.L. c. 260, § 2A with the discovery rule. Massachusetts plaintiffs file in MDL 2921 in the District of New Jersey — a convenient neighboring district. Boston's cosmetic surgery market and the prominence of Massachusetts General Hospital, Brigham and Women's Hospital, and Dana-Farber Cancer Institute as BIA-ALCL referral centers means that Massachusetts patients may receive their BIA-ALCL diagnosis at world-class lymphoma centers. The quality of pathology and oncology documentation from Boston's medical institutions supports strong causation evidence in MDL 2921 cases.
Exposure in Massachusetts
Source: FDA MAUDE Adverse Event Database
Source: FDA Adverse Event Reporting System